Commentary: vedolizumab: a new mechanism of action for the treatment of ulcerative colitis.

Authors:
Stefan Schreiber
Year of publication:
2014
Volume:
10
Issue:
1
Issn:
1554-7914
Journal title abbreviated:
Gastroenterol Hepatol (N Y)
Journal title long:
Gastroenterology & hepatology
Abstract: